Abiraterone Acetate Withdrawal Syndrome: Does It Exist?

In 2011 abiraterone acetate (AA) was approved for the treatment of castrate-resistant metastatic prostate cancer patients who have failed docetaxel chemotherapy. We report the case of a patient who experienced a confirmed PSA decrease of ≤50% after stopping AA, mimicking an antiandrogen withdrawal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gauthier, Hélène, Bousquet, Guilhem, Pouessel, Damien, Culine, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published online: July, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409514/
https://www.ncbi.nlm.nih.gov/pubmed/23525261
http://dx.doi.org/10.1159/000341564
_version_ 1782239599928541184
author Gauthier, Hélène
Bousquet, Guilhem
Pouessel, Damien
Culine, Stéphane
author_facet Gauthier, Hélène
Bousquet, Guilhem
Pouessel, Damien
Culine, Stéphane
author_sort Gauthier, Hélène
collection PubMed
description In 2011 abiraterone acetate (AA) was approved for the treatment of castrate-resistant metastatic prostate cancer patients who have failed docetaxel chemotherapy. We report the case of a patient who experienced a confirmed PSA decrease of ≤50% after stopping AA, mimicking an antiandrogen withdrawal syndrome.
format Online
Article
Text
id pubmed-3409514
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-34095142013-03-22 Abiraterone Acetate Withdrawal Syndrome: Does It Exist? Gauthier, Hélène Bousquet, Guilhem Pouessel, Damien Culine, Stéphane Case Rep Oncol Published online: July, 2012 In 2011 abiraterone acetate (AA) was approved for the treatment of castrate-resistant metastatic prostate cancer patients who have failed docetaxel chemotherapy. We report the case of a patient who experienced a confirmed PSA decrease of ≤50% after stopping AA, mimicking an antiandrogen withdrawal syndrome. S. Karger AG 2012-07-24 /pmc/articles/PMC3409514/ /pubmed/23525261 http://dx.doi.org/10.1159/000341564 Text en Copyright © 2012 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published online: July, 2012
Gauthier, Hélène
Bousquet, Guilhem
Pouessel, Damien
Culine, Stéphane
Abiraterone Acetate Withdrawal Syndrome: Does It Exist?
title Abiraterone Acetate Withdrawal Syndrome: Does It Exist?
title_full Abiraterone Acetate Withdrawal Syndrome: Does It Exist?
title_fullStr Abiraterone Acetate Withdrawal Syndrome: Does It Exist?
title_full_unstemmed Abiraterone Acetate Withdrawal Syndrome: Does It Exist?
title_short Abiraterone Acetate Withdrawal Syndrome: Does It Exist?
title_sort abiraterone acetate withdrawal syndrome: does it exist?
topic Published online: July, 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409514/
https://www.ncbi.nlm.nih.gov/pubmed/23525261
http://dx.doi.org/10.1159/000341564
work_keys_str_mv AT gauthierhelene abirateroneacetatewithdrawalsyndromedoesitexist
AT bousquetguilhem abirateroneacetatewithdrawalsyndromedoesitexist
AT pouesseldamien abirateroneacetatewithdrawalsyndromedoesitexist
AT culinestephane abirateroneacetatewithdrawalsyndromedoesitexist

Ejemplares similares